tilAZCD41C0 201807012024121320241231cM1c0: Fjernmetastase, LDH ikke forhøjet SKS 3 tilAZCD41C0 202501012024121325000101cM1cA: Fjernmetastase, LDH ikke forhøjet SKS 1 tilAZCD41C1 201807012024121320241231cM1c1: Fjernmetastase, LDH forhøjet SKS 3 tilAZCD41C1 202501012024121325000101cM1cB: Fjernmetastase, LDH forhøjet SKS 1 tilAZCD41C2 202501012024121325000101cM1c1: Fjernmetastase SKS 1 tilAZCD41C3 202501012024121325000101cM1c2: Fjernmetastase SKS 1 tilZDA03B 202501012024121325000101Anastomoselækage, type SKS 1 tilZDA03BA 202501012024121325000101anastomoselækage, type A SKS 1 tilZDA03BB 202501012024121325000101anastomoselækage, type B SKS 1 tilZDA03BC 202501012024121325000101anastomoselækage, type C SKS 1 tilZDW58B 202501012024121325000101veneinvasion påvist SKS 1 tilZDW58B1 202501012024121325000101veneinvasion påvist ved MR-skanning SKS 1 tilZM81401 200310012024121320241231adenom, usikkert om benignt eller malignt SKS 3 tilZM81401 202501012024121325000101atypisk parathyroidea tumor SKS 1 tilZM967D2 202501012024121325000101lavmalignt B-cellelymfom i inkomplet remission SKS 1 tilZM967D3 202501012024121325000101lavmalignt B-cellelymfom SKS 1 tilZM967D7 202501012024121325000101lavmalignt B-cellelymfom, recidiv SKS 1 tilZM967D8 202501012024121325000101lavmalignt B-cellelymfom i remission SKS 1 tilZM968I2 202410012024121320241231high-grade B-lymfom m. MYC og BCL2 rearr i inkomplet rem SKS 3 tilZM968I2 202501012024121325000101DLBCL/high-grade B-lymfom m. MYC og BCL2 rearr i inkomp rem SKS 1 tilZM968I3 202410012024121320241231high-grade B-lymfom m. MYC og BCL2 rearr SKS 3 tilZM968I3 202501012024121325000101DLBCL/high-grade B-lymfom m. MYC og BCL2 rearrangement SKS 1 tilZM968I7 202410012024121320241231high-grade B-lymfom m. MYC og BCL2 rearr, recidiv SKS 3 tilZM968I7 202501012024121325000101DLBCL/high-grade B-lymfom m. MYC og BCL2 rearr, recidiv SKS 1 tilZM968I8 202410012024121320241231high-grade B-lymfom m. MYC og BCL2 rearr i remission SKS 3 tilZM968I8 202501012024121325000101DLBCL/high-grade B-lymfom m. MYC og BCL2 rearr i remission SKS 1 tilZM96982 202501012024121325000101follikulært storcellet B-cellelymfom i inkomplet remission SKS 1 tilZM96983 202501012024121325000101follikulært storcellet B-cellelymfom SKS 1 tilZM96987 202501012024121325000101follikulært storcellet B-cellelymfom, recidiv SKS 1 tilZM96988 202501012024121325000101follikulært storcellet B-cellelymfom i remission SKS 1 tilZM969J2 202501012024121325000101højmalignt B-cellelymfom i inkomplet remission SKS 1 tilZM969J3 202501012024121325000101højmalignt B-cellelymfom SKS 1 tilZM969J7 202501012024121325000101højmalignt B-cellelymfom, recidiv SKS 1 tilZM969J8 202501012024121325000101højmalignt B-cellelymfom i remission SKS 1 tilZM98372 200310012024121320241231precursor T-lymfoblastisk leukæmi i inkomplet remission SKS 3 tilZM98372 202501012024121325000101T-lymfoblastisk leukæmi/lymfom i inkomplet remission SKS 1 tilZM98373 200310012024121320241231precursor T-lymfoblastisk leukæmi SKS 3 tilZM98373 202501012024121325000101T-lymfoblastisk leukæmi/lymfom SKS 1 tilZM98377 200310012024121320241231precursor T-lymfoblastisk leukæmi, recidiv SKS 3 tilZM98377 202501012024121325000101T-lymfoblastisk leukæmi/lymfom, recidiv SKS 1 tilZM98378 200310012024121320241231precursor T-lymfoblastisk leukæmi i remission SKS 3 tilZM98378 202501012024121325000101T-lymfoblastisk leukæmi/lymfom i remission SKS 1 tilZM986G3 202501012024121325000101myeloid neoplasi SKS 1 tilZM986G7 202501012024121325000101myeloid neoplasi, recidiv SKS 1 tilZM986G8 202501012024121325000101myeloid neoplasi i remission SKS 1 tilZM99613 201807012024121320241231myelofibrose SKS 3 tilZM99613 202501012024121325000101primær myelofibrose SKS 1 tilZM99617 201807012024121320241231myelofibrose, recidiv SKS 3 tilZM99617 202501012024121325000101primær myelofibrose, recidiv SKS 1 tilZM99618 201807012024121320241231myelofibrose i remission SKS 3 tilZM99618 202501012024121325000101primær myelofibrose i remission SKS 1 tilZM996E3 202501012024121325000101myelofibrose SKS 1 tilZM996E7 202501012024121325000101myelofibrose, recidiv SKS 1 tilZM996E8 202501012024121325000101myelofibrose i remission SKS 1 tilZM99711 202410012024121320241231polymorf lymfoproliferativ sygdom ved nedsat immunforsvar SKS 3 tilZM99711 202501012024121325000101polymorf lymfoproliferativ sygdom SKS 1 tilZM997A1 202410012024121320241231plasmacytær hyperplasi ved nedsat immunforsvar SKS 3 tilZM997A1 202501012024121325000101plasmacytær hyperplasi SKS 1 tilZM997B1 202410012024121320241231infektiøs mononukleoselign hyperpl ved nedsat immunforsvar SKS 3 tilZM997B1 202501012024121325000101infektiøs mononukleoselignde hyperplasi SKS 1 tilZM997C1 202410012024121320241231florid follikulær hyperplasi ved nedsat immunforsvar SKS 3 tilZM997C1 202501012024121325000101florid follikulær hyperplasi SKS 1 tilZM99894 202410012024121320241231myelodysplastisk neoplasi (MDS), direkte spredning SKS 3 tilZM99896 202410012024121320241231metastase, myelodysplastisk neoplasi (MDS) SKS 3 tilZPZA02E 202501012024121325000101downstaging mhp. senere resektion SKS 1